Skip to main content
Top
Published in: BMC Geriatrics 1/2019

Open Access 01-12-2019 | Sarcopenia | Research article

The impact of muscle function, muscle mass and sarcopenia on independent ageing in very old Swedish men

Authors: Kristin Franzon, Björn Zethelius, Tommy Cederholm, Lena Kilander

Published in: BMC Geriatrics | Issue 1/2019

Login to get access

Abstract

Background

Preserved functions of daily life and cognition are cornerstones of independent aging, which is crucial for maintaining a high quality of life. The aim of this study was to examine the impact of sarcopenia, and its underlying components, on independent ageing in a cohort study of very old men.

Methods

The presence of sarcopenia and independent ageing at a mean age of 87 was investigated in 287 men from the Uppsala Longitudinal Study of Adult Men. Five years later 127 men were re-evaluated for independent ageing. Sarcopenia was defined by two different definitions from the European Working Group on Sarcopenia in Older People. In the first definition sarcopenia was defined as skeletal muscle index < 7.26 kg/m2 and either gait speed ≤0.8 m/s or hand grip strength < 30 kg. In the later up-dated definition, HGS < 27 kg and/or chair stand test > 15 s defines probable sarcopenia, which is confirmed by SMI < 7.0 kg/m2. Independent ageing was defined as a Mini-Mental State Examination score of ≥25 points, absence of diagnosed dementia, community-dwelling, independency in personal care and ability to walk outdoors alone.

Results

Sarcopenia at baseline was observed in 21% (60/287) and 20% (58/287), respectively, due to definition. The prevalence of independent ageing was 83% (239/288) at baseline and 69% (87/127) five years later. None of the sarcopenia diagnoses were associated with independent ageing. In contrast, gait speed was both in cross-sectional (odds ratio (OR) per one standard deviation increase 2.15, 95% confidence interval (CI) 1.47–3.15), and in longitudinal multivariate analyses (OR 1.84, 95% CI 1.19–2.82). In the cross-sectional analysis also higher hand grip strength was associated with independent ageing (OR 1.58, 95% CI 1.12–2.22), while a slower chair stand test was inversely associated (OR 0.61, 95% CI 0.43–0.86). Muscle mass; i.e. skeletal muscle index, was not associated with independent ageing.

Conclusions

For very old men, especially a higher gait speed, but also a higher hand grip strength and a faster chair stand test, were associated with independent ageing, while skeletal muscle index alone, and the composite sarcopenia phenotype measured with two different definitions, were not.
Literature
1.
go back to reference Hofman CS, Makai P, Boter H, et al. The influence of age on health valuations: the older olds prefer functional independence while the younger olds prefer less morbidity. Clin Interv Aging. 2015;10:1131–9.CrossRef Hofman CS, Makai P, Boter H, et al. The influence of age on health valuations: the older olds prefer functional independence while the younger olds prefer less morbidity. Clin Interv Aging. 2015;10:1131–9.CrossRef
2.
go back to reference Franzon K, Zethelius B, Cederholm T, et al. Modifiable midlife risk factors, independent aging, and survival in older men: report on long-term follow-up of the Uppsala longitudinal study of adult men cohort. J Am Geriatr Soc. 2015;63(5):877–85.CrossRef Franzon K, Zethelius B, Cederholm T, et al. Modifiable midlife risk factors, independent aging, and survival in older men: report on long-term follow-up of the Uppsala longitudinal study of adult men cohort. J Am Geriatr Soc. 2015;63(5):877–85.CrossRef
3.
go back to reference Franzon K, Byberg L, Sjogren P, et al. Predictors of independent aging and survival: a 16-year follow-up report in octogenarian men. J Am Geriatr Soc. 2017;65(9):1953–60.CrossRef Franzon K, Byberg L, Sjogren P, et al. Predictors of independent aging and survival: a 16-year follow-up report in octogenarian men. J Am Geriatr Soc. 2017;65(9):1953–60.CrossRef
4.
go back to reference Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(5 Suppl):990S–1S.CrossRef Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(5 Suppl):990S–1S.CrossRef
5.
go back to reference Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010;39(4):412–23.CrossRef Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010;39(4):412–23.CrossRef
6.
go back to reference Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249–56.CrossRef Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249–56.CrossRef
7.
go back to reference Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547–58.CrossRef Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547–58.CrossRef
8.
go back to reference Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.CrossRef Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.CrossRef
9.
go back to reference Su Y, Hirayama K, Han TF, et al. Sarcopenia Prevalence and Risk Factors among Japanese Community Dwelling Older Adults Living in a Snow-Covered City According to EWGSOP2. J Clin Med. 2019:8(3).CrossRef Su Y, Hirayama K, Han TF, et al. Sarcopenia Prevalence and Risk Factors among Japanese Community Dwelling Older Adults Living in a Snow-Covered City According to EWGSOP2. J Clin Med. 2019:8(3).CrossRef
10.
go back to reference Locquet M, Beaudart C, Petermans J, et al. EWGSOP2 versus EWGSOP1: impact on the prevalence of sarcopenia and its major health consequences. J Am Med Dir Assoc. 2019;20(3):384–5.CrossRef Locquet M, Beaudart C, Petermans J, et al. EWGSOP2 versus EWGSOP1: impact on the prevalence of sarcopenia and its major health consequences. J Am Med Dir Assoc. 2019;20(3):384–5.CrossRef
11.
go back to reference Beaudart C, Zaaria M, Pasleau F, et al. Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One. 2017;12(1):e0169548.CrossRef Beaudart C, Zaaria M, Pasleau F, et al. Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One. 2017;12(1):e0169548.CrossRef
12.
go back to reference Chang KV, Hsu TH, Wu WT, et al. Association Between Sarcopenia and Cognitive Impairment: A Systematic Review and Meta-Analysis. J Am Med Dir Assoc. 2016;17(12):1164 e1167–15.CrossRef Chang KV, Hsu TH, Wu WT, et al. Association Between Sarcopenia and Cognitive Impairment: A Systematic Review and Meta-Analysis. J Am Med Dir Assoc. 2016;17(12):1164 e1167–15.CrossRef
13.
go back to reference Abellan van Kan G, Cesari M, Gillette-Guyonnet S, et al. Sarcopenia and cognitive impairment in elderly women: results from the EPIDOS cohort. Age Ageing. 2013;42(2):196–202.CrossRef Abellan van Kan G, Cesari M, Gillette-Guyonnet S, et al. Sarcopenia and cognitive impairment in elderly women: results from the EPIDOS cohort. Age Ageing. 2013;42(2):196–202.CrossRef
14.
go back to reference Hsu YH, Liang CK, Chou MY, et al. Association of cognitive impairment, depressive symptoms and sarcopenia among healthy older men in the veterans retirement community in southern Taiwan: a cross-sectional study. Geriatr Gerontol Int. 2014;14(Suppl 1):102–8.CrossRef Hsu YH, Liang CK, Chou MY, et al. Association of cognitive impairment, depressive symptoms and sarcopenia among healthy older men in the veterans retirement community in southern Taiwan: a cross-sectional study. Geriatr Gerontol Int. 2014;14(Suppl 1):102–8.CrossRef
15.
go back to reference Tolea MI, Galvin JE. Sarcopenia and impairment in cognitive and physical performance. Clin Interv Aging. 2015;10:663–71.CrossRef Tolea MI, Galvin JE. Sarcopenia and impairment in cognitive and physical performance. Clin Interv Aging. 2015;10:663–71.CrossRef
16.
go back to reference Rantanen KK, Strandberg TE, Stenholm SS, et al. Clinical and laboratory characteristics of active and healthy aging (AHA) in octogenarian men. Aging Clin Exp Res. 2015;27(5):581–7.CrossRef Rantanen KK, Strandberg TE, Stenholm SS, et al. Clinical and laboratory characteristics of active and healthy aging (AHA) in octogenarian men. Aging Clin Exp Res. 2015;27(5):581–7.CrossRef
17.
go back to reference Tyrovolas S, Haro JM, Mariolis A, et al. Skeletal muscle mass and body fat in relation to successful ageing of older adults: the multi-national MEDIS study. Arch Gerontol Geriatr. 2016;66:95–101.CrossRef Tyrovolas S, Haro JM, Mariolis A, et al. Skeletal muscle mass and body fat in relation to successful ageing of older adults: the multi-national MEDIS study. Arch Gerontol Geriatr. 2016;66:95–101.CrossRef
18.
go back to reference Bell CL, Chen R, Masaki K, et al. Late-life factors associated with healthy aging in older men. J Am Geriatr Soc. 2014;62(5):880–8.CrossRef Bell CL, Chen R, Masaki K, et al. Late-life factors associated with healthy aging in older men. J Am Geriatr Soc. 2014;62(5):880–8.CrossRef
20.
go back to reference Lochen ML, Rasmussen K. The Tromso study: physical fitness, self reported physical activity, and their relationship to other coronary risk factors. J Epidemiol Community Health. 1992;46(2):103–7.CrossRef Lochen ML, Rasmussen K. The Tromso study: physical fitness, self reported physical activity, and their relationship to other coronary risk factors. J Epidemiol Community Health. 1992;46(2):103–7.CrossRef
21.
go back to reference Aires N, Selmer R, Thelle D. The validity of self-reported leisure time physical activity, and its relationship to serum cholesterol, blood pressure and body mass index. A population based study of 332,182 men and women aged 40-42 years. Eur J Epidemiol. 2003;18(6):479–85.CrossRef Aires N, Selmer R, Thelle D. The validity of self-reported leisure time physical activity, and its relationship to serum cholesterol, blood pressure and body mass index. A population based study of 332,182 men and women aged 40-42 years. Eur J Epidemiol. 2003;18(6):479–85.CrossRef
22.
go back to reference Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRef Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRef
23.
go back to reference Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–9.CrossRef Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–9.CrossRef
24.
go back to reference Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.CrossRef Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.CrossRef
25.
go back to reference American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, DC.; 1994. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, DC.; 1994.
26.
go back to reference McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34(7):939–44.CrossRef McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34(7):939–44.CrossRef
27.
go back to reference McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the work group on frontotemporal dementia and Pick's disease. Arch Neurol. 2001;58(11):1803–9.CrossRef McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the work group on frontotemporal dementia and Pick's disease. Arch Neurol. 2001;58(11):1803–9.CrossRef
28.
go back to reference Chui HC, Victoroff JI, Margolin D, et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's disease diagnostic and treatment centers. Neurology. 1992;42(3 Pt 1):473–80.CrossRef Chui HC, Victoroff JI, Margolin D, et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's disease diagnostic and treatment centers. Neurology. 1992;42(3 Pt 1):473–80.CrossRef
29.
go back to reference McKeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. J Alzheimers Dis. 2006;9(3 Suppl):417–23.CrossRef McKeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. J Alzheimers Dis. 2006;9(3 Suppl):417–23.CrossRef
30.
go back to reference Woo J, Leung J, Zhang T. Successful aging and frailty: opposite sides of the same coin? J Am Med Dir Assoc. 2016;17(9):797–801.CrossRef Woo J, Leung J, Zhang T. Successful aging and frailty: opposite sides of the same coin? J Am Med Dir Assoc. 2016;17(9):797–801.CrossRef
31.
go back to reference Rijk JM, Roos PR, Deckx L, et al. Prognostic value of handgrip strength in people aged 60 years and older: a systematic review and meta-analysis. Geriatr Gerontol Int. 2016;16(1):5–20.CrossRef Rijk JM, Roos PR, Deckx L, et al. Prognostic value of handgrip strength in people aged 60 years and older: a systematic review and meta-analysis. Geriatr Gerontol Int. 2016;16(1):5–20.CrossRef
32.
go back to reference Perera S, Patel KV, Rosano C, et al. Gait speed predicts incident disability: a pooled analysis. J Gerontol A Biol Sci Med Sci. 2016;71(1):63–71.CrossRef Perera S, Patel KV, Rosano C, et al. Gait speed predicts incident disability: a pooled analysis. J Gerontol A Biol Sci Med Sci. 2016;71(1):63–71.CrossRef
33.
go back to reference Demnitz N, Esser P, Dawes H, et al. A systematic review and meta-analysis of cross-sectional studies examining the relationship between mobility and cognition in healthy older adults. Gait Posture. 2016;50:164–74.CrossRef Demnitz N, Esser P, Dawes H, et al. A systematic review and meta-analysis of cross-sectional studies examining the relationship between mobility and cognition in healthy older adults. Gait Posture. 2016;50:164–74.CrossRef
34.
go back to reference Quan M, Xun P, Chen C, et al. Walking pace and the risk of cognitive decline and dementia in elderly populations: a meta-analysis of prospective cohort studies. J Gerontol A Biol Sci Med Sci. 2017;72(2):266–70.CrossRef Quan M, Xun P, Chen C, et al. Walking pace and the risk of cognitive decline and dementia in elderly populations: a meta-analysis of prospective cohort studies. J Gerontol A Biol Sci Med Sci. 2017;72(2):266–70.CrossRef
35.
go back to reference Mielke MM, Roberts RO, Savica R, et al. Assessing the temporal relationship between cognition and gait: slow gait predicts cognitive decline in the Mayo Clinic study of aging. J Gerontol A Biol Sci Med Sci. 2013;68(8):929–37.CrossRef Mielke MM, Roberts RO, Savica R, et al. Assessing the temporal relationship between cognition and gait: slow gait predicts cognitive decline in the Mayo Clinic study of aging. J Gerontol A Biol Sci Med Sci. 2013;68(8):929–37.CrossRef
36.
go back to reference Papachristou E, Ramsay SE, Lennon LT, et al. The relationships between body composition characteristics and cognitive functioning in a population-based sample of older British men. BMC Geriatr. 2015;15:172.CrossRef Papachristou E, Ramsay SE, Lennon LT, et al. The relationships between body composition characteristics and cognitive functioning in a population-based sample of older British men. BMC Geriatr. 2015;15:172.CrossRef
37.
go back to reference Bullain SS, Corrada MM, Shah BA, et al. Poor physical performance and dementia in the oldest old: the 90+ study. JAMA Neurol. 2013;70(1):107–13.CrossRef Bullain SS, Corrada MM, Shah BA, et al. Poor physical performance and dementia in the oldest old: the 90+ study. JAMA Neurol. 2013;70(1):107–13.CrossRef
38.
go back to reference Cohen JA, Verghese J, Zwerling JL. Cognition and gait in older people. Maturitas. 2016;93:73–7.CrossRef Cohen JA, Verghese J, Zwerling JL. Cognition and gait in older people. Maturitas. 2016;93:73–7.CrossRef
39.
go back to reference Hsu CL, Liang CK, Liao MC, et al. Slow gait speed as a predictor of 1-year cognitive decline in a veterans’ retirement community in southern Taiwan. Geriatr Gerontol Int. 2017;17(Suppl 1):14–9.CrossRef Hsu CL, Liang CK, Liao MC, et al. Slow gait speed as a predictor of 1-year cognitive decline in a veterans’ retirement community in southern Taiwan. Geriatr Gerontol Int. 2017;17(Suppl 1):14–9.CrossRef
40.
go back to reference Fougere B, Daumas M, Lilamand M, et al. Association Between Frailty and Cognitive Impairment: Cross-Sectional Data From Toulouse Frailty Day Hospital. J Am Med Dir Assoc. 2017;18(11):990 e991–5.CrossRef Fougere B, Daumas M, Lilamand M, et al. Association Between Frailty and Cognitive Impairment: Cross-Sectional Data From Toulouse Frailty Day Hospital. J Am Med Dir Assoc. 2017;18(11):990 e991–5.CrossRef
41.
go back to reference Taekema DG, Gussekloo J, Maier AB, et al. Handgrip strength as a predictor of functional, psychological and social health. A prospective population-based study among the oldest old. Age Ageing. 2010;39(3):331–7.CrossRef Taekema DG, Gussekloo J, Maier AB, et al. Handgrip strength as a predictor of functional, psychological and social health. A prospective population-based study among the oldest old. Age Ageing. 2010;39(3):331–7.CrossRef
42.
go back to reference Bullain SS, Corrada MM, Perry SM, et al. Sound body sound mind? Physical performance and the risk of dementia in the oldest-old: the 90+ study. J Am Geriatr Soc. 2016;64(7):1408–15.CrossRef Bullain SS, Corrada MM, Perry SM, et al. Sound body sound mind? Physical performance and the risk of dementia in the oldest-old: the 90+ study. J Am Geriatr Soc. 2016;64(7):1408–15.CrossRef
43.
go back to reference Rothman MD, Leo-Summers L, Gill TM. Prognostic significance of potential frailty criteria. J Am Geriatr Soc. 2008;56(12):2211–6.CrossRef Rothman MD, Leo-Summers L, Gill TM. Prognostic significance of potential frailty criteria. J Am Geriatr Soc. 2008;56(12):2211–6.CrossRef
44.
go back to reference Onder G, Penninx BW, Ferrucci L, et al. Measures of physical performance and risk for progressive and catastrophic disability: results from the Women's health and aging study. J Gerontol A Biol Sci Med Sci. 2005;60(1):74–9.CrossRef Onder G, Penninx BW, Ferrucci L, et al. Measures of physical performance and risk for progressive and catastrophic disability: results from the Women's health and aging study. J Gerontol A Biol Sci Med Sci. 2005;60(1):74–9.CrossRef
45.
go back to reference Heiland EG, Welmer AK, Wang R, et al. Association of mobility limitations with incident disability among older adults: a population-based study. Age Ageing. 2016;45(6):812–9.CrossRef Heiland EG, Welmer AK, Wang R, et al. Association of mobility limitations with incident disability among older adults: a population-based study. Age Ageing. 2016;45(6):812–9.CrossRef
46.
go back to reference Abellan van Kan G, Rolland Y, Gillette-Guyonnet S, et al. Gait speed, body composition, and dementia. The EPIDOS-Toulouse cohort. J Gerontol A Biol Sci Med Sci. 2012;67(4):425–32.CrossRef Abellan van Kan G, Rolland Y, Gillette-Guyonnet S, et al. Gait speed, body composition, and dementia. The EPIDOS-Toulouse cohort. J Gerontol A Biol Sci Med Sci. 2012;67(4):425–32.CrossRef
47.
go back to reference Rolland Y, Lauwers-Cances V, Cristini C, et al. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) study. Am J Clin Nutr. 2009;89(6):1895–900.CrossRef Rolland Y, Lauwers-Cances V, Cristini C, et al. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) study. Am J Clin Nutr. 2009;89(6):1895–900.CrossRef
48.
go back to reference Hirani V, Blyth F, Naganathan V, et al. Sarcopenia is associated with incident disability, institutionalization, and mortality in community-dwelling older men: the Concord health and ageing in men project. J Am Med Dir Assoc. 2015;16(7):607–13.CrossRef Hirani V, Blyth F, Naganathan V, et al. Sarcopenia is associated with incident disability, institutionalization, and mortality in community-dwelling older men: the Concord health and ageing in men project. J Am Med Dir Assoc. 2015;16(7):607–13.CrossRef
49.
go back to reference Mitchell WK, Williams J, Atherton P, et al. Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol. 2012;3:260.CrossRef Mitchell WK, Williams J, Atherton P, et al. Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol. 2012;3:260.CrossRef
50.
go back to reference Pagotto V, Silveira EA. Applicability and agreement of different diagnostic criteria for sarcopenia estimation in the elderly. Arch Gerontol Geriatr. 2014;59(2):288–94.CrossRef Pagotto V, Silveira EA. Applicability and agreement of different diagnostic criteria for sarcopenia estimation in the elderly. Arch Gerontol Geriatr. 2014;59(2):288–94.CrossRef
51.
go back to reference Dodds RM, Granic A, Davies K, et al. Prevalence and incidence of sarcopenia in the very old: findings from the Newcastle 85+ study. J Cachexia Sarcopenia Muscle. 2017;8(2):229–37.CrossRef Dodds RM, Granic A, Davies K, et al. Prevalence and incidence of sarcopenia in the very old: findings from the Newcastle 85+ study. J Cachexia Sarcopenia Muscle. 2017;8(2):229–37.CrossRef
52.
go back to reference Volpato S, Bianchi L, Cherubini A, et al. Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci. 2014;69(4):438–46.CrossRef Volpato S, Bianchi L, Cherubini A, et al. Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci. 2014;69(4):438–46.CrossRef
53.
go back to reference Legrand D, Vaes B, Mathei C, et al. The prevalence of sarcopenia in very old individuals according to the European consensus definition: insights from the BELFRAIL study. Age Ageing. 2013;42(6):727–34.CrossRef Legrand D, Vaes B, Mathei C, et al. The prevalence of sarcopenia in very old individuals according to the European consensus definition: insights from the BELFRAIL study. Age Ageing. 2013;42(6):727–34.CrossRef
54.
go back to reference Chang KV, Hsu TH, Wu WT, et al. Is sarcopenia associated with depression? A systematic review and meta-analysis of observational studies. Age Ageing. 2017;46(5):738–46.CrossRef Chang KV, Hsu TH, Wu WT, et al. Is sarcopenia associated with depression? A systematic review and meta-analysis of observational studies. Age Ageing. 2017;46(5):738–46.CrossRef
55.
go back to reference Bohannon RW, Williams Andrews A. Normal walking speed: a descriptive meta-analysis. Physiotherapy. 2011;97(3):182–9.CrossRef Bohannon RW, Williams Andrews A. Normal walking speed: a descriptive meta-analysis. Physiotherapy. 2011;97(3):182–9.CrossRef
Metadata
Title
The impact of muscle function, muscle mass and sarcopenia on independent ageing in very old Swedish men
Authors
Kristin Franzon
Björn Zethelius
Tommy Cederholm
Lena Kilander
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2019
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-019-1142-y

Other articles of this Issue 1/2019

BMC Geriatrics 1/2019 Go to the issue